![MSK scientists Andrew Kung and Elli Papaemmanouil](https://www.sloankettering.edu/sites/default/files/styles/width_200/public/node/245512/main_image/kungpapaemmanuil-12x8.jpg)
New Type of Genetic Testing Aims To Benefit Children and Young Adults With Cancer
By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults.
In the Clinic
![Molecular geneticist Elli Papaemmanouil](https://www.sloankettering.edu/sites/default/files/styles/width_200/public/node/123277/main_image/2017msk_mp_10_epibiolab_085.nef.p2.1200x800.jpg)
New Research Shows AML Is Not One Disease, But 11 or More
Learn how researchers plan to use new genetic information about acute myeloid leukemia to tailor treatments.
![MSK molecular geneticist Elli Papaemmanouil](https://www.sloankettering.edu/sites/default/files/styles/width_200/public/node/201502/main_image/2017msk_mp_10_epibiolab_084.nef.p2-1200x800.jpg)
Large International Study Pinpoints Impact of TP53 Gene Mutations on Blood Cancer Severity
Having two mutated copies of the TP53 gene — as opposed to a single mutated copy — is associated with worse outcomes in a blood cancer called myelodysplastic syndrome, according to a new study led by researchers at Memorial Sloan Kettering.
Finding
![Researchers Ahmet Zehir and Elli Papaemmanouil talk while looking at a computer.](https://www.sloankettering.edu/sites/default/files/styles/width_200/public/node/211840/main_image/msk_201020_017-1200x800.jpg)
Why Do Certain Chemotherapies Increase the Likelihood of Blood Cancer?
New research focuses on clonal hematopoiesis, an age-related blood condition that increases the risk of blood cancer.